In addition, NLR is a simple and easily available marker to predict the development of SIRS or sepsis after PCNL compared to more expensive tests such as PCT and IL-6, but the lack of consensus on the optimal cut-off value for NLR limits its use in clinical practice, and therefore prospective multicenter studies with large samples are needed to improve evidence and standardization. This evidence concerns the gene IL6 and Sepsis.